No upregulation of cGAS was found in more advanced stage tumors, suggesting that although cGAS is upregulated in early-stage colon cancers, the cGAS-mediated immune stimulation might contribute partially to preventing CRC progression (Hu et al., 2021b). The gene discussed is CGAS; the disease is colorectal carcinoma.